JPRN-UMIN000008567尚未招募2 期
Chemopreventive effect of Minodronic acid hydrate for the patients treated with Aromatase inhibitor - Chemopreventive effect of Minodronic acid hydrate for the patients treated with AI
The University of Tokushima graduate school0 个研究点目标入组 50 人开始时间: 2012年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients cannot use Minodronic acid hydrate
研究者
相似试验
已完成
不适用
Examination of utility of minodronic acid hydrate to osteoporosis by ovarian insufficiency after gynecologic disease treatmentOsteoporosis after gynecologic disease treatmentJPRN-UMIN000008353Gifu University30
尚未招募
2 期
Efficasy of Minodronic acid hydrate for the patients treated with Aromatase inhibitorBreast cancerJPRN-UMIN000008566Tokushima University Hospital50
已完成
不适用
Efficacy of minodronic acid hydrate in patients with osteoporosisosteoporosisJPRN-UMIN000011846Tottori University, Faculty of Medicine, School of Health Science120
招募中
4 期
Efficacy of minodronic acid hydrate to osteoporotic patientsosteoporosisJPRN-UMIN000008931Gerontology,Graduate School of Medicine, Osaka City University60
尚未招募
不适用
Effect of minodronate for preventring secondary fragility fractures in postoperative hip fractures of oseteoporotic patients.OsteoporosisJPRN-UMIN000018492agano Red Cross Hospital400